Microbot Medical Inc MBOT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Microbot Medical® Strengthens IP Portfolio as it Continues to Establish Infrastructure to Support Future Commercialization Expansion
Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System
Microbot Medical® Attending Key Medical Conference to Engage with Decision-makers as it Continues to Expand Presence Across the U.S.
Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio
Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
Microbot Medical® Highlights Growth Strategy
Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
Trading Information
- Previous Close Price
- $1.07
- Day Range
- $1.08–1.08
- 52-Week Range
- $0.94–2.85
- Bid/Ask
- $1.10 / $1.11
- Shares Outstanding
- 67.16M
- Market Cap
- $73.21M
- Volume/Avg
- 76,580 / 754,247
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 193.18
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 22
Valuation
Metric | MBOT |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.04 |
Price/Sales | 193.18 |
Price/Cash Flow | — |
Price/Earnings
MBOT
Financial Strength
Metric | MBOT |
|---|---|
Quick Ratio | 17.37 |
Current Ratio | 18.56 |
Interest Coverage | — |
Quick Ratio
MBOT
Profitability
Metric | MBOT |
|---|---|
Return on Assets (Normalized) | −21.73% |
Return on Equity (Normalized) | −22.97% |
Return on Invested Capital (Normalized) | −25.97% |
Return on Assets
MBOT
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|!?S^Y> | LOCK|fF&V | $197B | |||
| Medtronic PLC MDT | LOCK|Vg%g@y! | LOCK|%t<@q | $134B | |||
| Stryker Corp SYK | LOCK|KJs<Xqx | LOCK|xH | $128B | |||
| Boston Scientific Corp BSX | LOCK|#?<c?$ | LOCK|#gdt | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|n?XZ<xl | LOCK|?$<k@ | $58B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|%@!T@@ | LOCK|$^l | $38B | |||
| DexCom Inc DXCM | LOCK|&>@$^%T | LOCK|>W!# | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|## | LOCK|w># | $30B | |||
| Steris PLC STE | LOCK|$&S^Y! | LOCK|%kWK | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|<>q?!rQ# | LOCK|Wk | $20B |
United States